Cargando…
The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil
OBJECTIVE: To describe the successful implementation of an enhanced public health surveillance system based on early detection, tracing contacts, and patient follow-up and support. STUDY DESIGN: A prospective observational cohort study conducted in Serrana, São Paulo State, Brazil. METHODS: The impl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354446/ https://www.ncbi.nlm.nih.gov/pubmed/35946045 http://dx.doi.org/10.1016/j.puhip.2022.100301 |
_version_ | 1784763073838448640 |
---|---|
author | Ferreira, Natasha N. Garibaldi, Pedro M.M. Moraes, Glenda R. Moura, José C. Klein, Taline M. Machado, Larissa E. Scofoni, Lilian F.B. Haddad, Simone K. Calado, Rodrigo T. Covas, Dimas T. Fonseca, Benedito A.L. Palacios, Ricardo Conde, Monica T.R.P. Borges, Marcos C. |
author_facet | Ferreira, Natasha N. Garibaldi, Pedro M.M. Moraes, Glenda R. Moura, José C. Klein, Taline M. Machado, Larissa E. Scofoni, Lilian F.B. Haddad, Simone K. Calado, Rodrigo T. Covas, Dimas T. Fonseca, Benedito A.L. Palacios, Ricardo Conde, Monica T.R.P. Borges, Marcos C. |
author_sort | Ferreira, Natasha N. |
collection | PubMed |
description | OBJECTIVE: To describe the successful implementation of an enhanced public health surveillance system based on early detection, tracing contacts, and patient follow-up and support. STUDY DESIGN: A prospective observational cohort study conducted in Serrana, São Paulo State, Brazil. METHODS: The implementation was based on four axes: increasing the access to SARS-CoV-2 testing; correct swab collection; testing patients with mild symptoms; and patient follow-up. Positivity rate, patient demographic and clinical characteristics, dynamics of disease severity, SARS-CoV-2 genome evolution, and the impact on COVID-19 research were assessed from August 23, 2020 to February 6, 2021 (between epidemiological week 35/2020 and 5/2021, a total of 24 weeks). RESULTS: The number of sites collecting rt-PCR for SARS-CoV-2 was increased from one to seven points and staff was trained in the correct use of personal protective equipment and in the swab collection technique. During the study period, 6728 samples were collected from 6155 participants vs. 2770 collections in a similar period before. SARS-CoV-2 RNA was detected in 1758 (26.1%) swabs vs. 1117 (36.7%) before the implementation of the surveillance system (p < 0.001). Positivity rates varied widely between epidemiological weeks 35/2020 and 5/2021 (IQR, 12.8%–31.3%). Out of COVID-19 patients, 91.1% were adults at a median age of 35 years (IQR, 25–50 years), 42.6% were men and 57.4% were women, with a SARS-CoV-2 positivity rate of 28.6% and 24.4% (p < 0.001), respectively. The most common symptoms were headache (72.6%), myalgia (65.0%), and cough (61.7%). Comorbidities were found in 20.8% of patients, the most common being hypertension and diabetes. According to the World Health Organization clinical progression scale, 93.5% of patients had mild disease, 1.6% were hospitalized with moderate disease, 3.2% were hospitalized with severe disease, and 1.4% died. The enhanced surveillance system led to the development of COVID-19 related research. CONCLUSIONS: The enhanced surveillance system in Serrana improved COVID-19 understanding and management. By integrating community and academic institutions, it was possible to monitor SARS-CoV-2 positive cases and variants, follow the epidemic trend, guide patients, and develop relevant research projects. |
format | Online Article Text |
id | pubmed-9354446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-93544462022-08-05 The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil Ferreira, Natasha N. Garibaldi, Pedro M.M. Moraes, Glenda R. Moura, José C. Klein, Taline M. Machado, Larissa E. Scofoni, Lilian F.B. Haddad, Simone K. Calado, Rodrigo T. Covas, Dimas T. Fonseca, Benedito A.L. Palacios, Ricardo Conde, Monica T.R.P. Borges, Marcos C. Public Health Pract (Oxf) Original Research OBJECTIVE: To describe the successful implementation of an enhanced public health surveillance system based on early detection, tracing contacts, and patient follow-up and support. STUDY DESIGN: A prospective observational cohort study conducted in Serrana, São Paulo State, Brazil. METHODS: The implementation was based on four axes: increasing the access to SARS-CoV-2 testing; correct swab collection; testing patients with mild symptoms; and patient follow-up. Positivity rate, patient demographic and clinical characteristics, dynamics of disease severity, SARS-CoV-2 genome evolution, and the impact on COVID-19 research were assessed from August 23, 2020 to February 6, 2021 (between epidemiological week 35/2020 and 5/2021, a total of 24 weeks). RESULTS: The number of sites collecting rt-PCR for SARS-CoV-2 was increased from one to seven points and staff was trained in the correct use of personal protective equipment and in the swab collection technique. During the study period, 6728 samples were collected from 6155 participants vs. 2770 collections in a similar period before. SARS-CoV-2 RNA was detected in 1758 (26.1%) swabs vs. 1117 (36.7%) before the implementation of the surveillance system (p < 0.001). Positivity rates varied widely between epidemiological weeks 35/2020 and 5/2021 (IQR, 12.8%–31.3%). Out of COVID-19 patients, 91.1% were adults at a median age of 35 years (IQR, 25–50 years), 42.6% were men and 57.4% were women, with a SARS-CoV-2 positivity rate of 28.6% and 24.4% (p < 0.001), respectively. The most common symptoms were headache (72.6%), myalgia (65.0%), and cough (61.7%). Comorbidities were found in 20.8% of patients, the most common being hypertension and diabetes. According to the World Health Organization clinical progression scale, 93.5% of patients had mild disease, 1.6% were hospitalized with moderate disease, 3.2% were hospitalized with severe disease, and 1.4% died. The enhanced surveillance system led to the development of COVID-19 related research. CONCLUSIONS: The enhanced surveillance system in Serrana improved COVID-19 understanding and management. By integrating community and academic institutions, it was possible to monitor SARS-CoV-2 positive cases and variants, follow the epidemic trend, guide patients, and develop relevant research projects. Elsevier 2022-08-05 /pmc/articles/PMC9354446/ /pubmed/35946045 http://dx.doi.org/10.1016/j.puhip.2022.100301 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Ferreira, Natasha N. Garibaldi, Pedro M.M. Moraes, Glenda R. Moura, José C. Klein, Taline M. Machado, Larissa E. Scofoni, Lilian F.B. Haddad, Simone K. Calado, Rodrigo T. Covas, Dimas T. Fonseca, Benedito A.L. Palacios, Ricardo Conde, Monica T.R.P. Borges, Marcos C. The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title | The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title_full | The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title_fullStr | The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title_full_unstemmed | The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title_short | The impact of an enhanced health surveillance system for COVID-19 management in Serrana, Brazil |
title_sort | impact of an enhanced health surveillance system for covid-19 management in serrana, brazil |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354446/ https://www.ncbi.nlm.nih.gov/pubmed/35946045 http://dx.doi.org/10.1016/j.puhip.2022.100301 |
work_keys_str_mv | AT ferreiranatashan theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT garibaldipedromm theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT moraesglendar theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT mourajosec theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT kleintalinem theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT machadolarissae theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT scofonililianfb theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT haddadsimonek theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT caladorodrigot theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT covasdimast theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT fonsecabeneditoal theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT palaciosricardo theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT condemonicatrp theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT borgesmarcosc theimpactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT ferreiranatashan impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT garibaldipedromm impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT moraesglendar impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT mourajosec impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT kleintalinem impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT machadolarissae impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT scofonililianfb impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT haddadsimonek impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT caladorodrigot impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT covasdimast impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT fonsecabeneditoal impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT palaciosricardo impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT condemonicatrp impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil AT borgesmarcosc impactofanenhancedhealthsurveillancesystemforcovid19managementinserranabrazil |